Main pageIndonesia

Welcome to PinkRibbon Indonesia

You’re not alone. This page shares key facts about common female cancers in Indonesia , survival stats, health initiatives, and trusted support organisations. Our mission is to ensure every woman has access to awareness, early detection, and compassionate care.

Cancer statistics
& survival rates

Cancer Statistics & Survival Rates in Indonesia
• Breast cancer: No national 5-year survival published; hospital cohorts suggest ~51% 5-year overall survival where late stage is common.
• Cervical cancer: ~36,633 new cases and ~21,003 deaths annually; 2nd most common in women.
• Ovarian/Endometrial/Vaginal/Vulvar: Nationwide survival figures not robust; outcomes vary by hospital and stage mix.

Recent research
& Initiatives

  • Recent Research/Initiatives
    • National Cancer Plan 2024–2034 (expands RT/nuclear medicine; screening benefits within BPJS).
    • Partnerships to strengthen the Dharmais National Cancer Center network.

    Learn more

Support organizations

  • • Yayasan Kanker Indonesia (YKI) – (021) 3920568 / Hotline Donasi (021) 3152603.
    • Yayasan Kanker Payudara Indonesia (YKPI) – 021-7202484 / WhatsApp +62 821-2364-2164

Accessing cancer screening and treatment

Where to get screened

These services are part of the national screening program “Prolamvano” (meaning “I Prevent”)

Learn more

  • Accessing Screening & Treatment
    • Breast: clinical breast exam recommended >40 within programmes; mammography from ~age 40.
    • Cervix: VIA screening for women 30–50 via public clinics (scale-up ongoing).

    Learn more

Support is nearby

Hotline numbers

• YKI: (021) 3920568 / (021) 3152603; YKPI: 021-7202484 / WA +62 821-2364-2164
Normal

Where to get treatment

Financial support

  • ) Financial Support
    • Coverage via JNK/BPJS at designated centres; social work desks can advise on assistance where needed.

  • Systematic challenges

    Systematic Challenges
    • Late presentation and low screening uptake, particularly outside major cities.
    • Radiotherapy capacity and tariff constraints; limited machines in some regions.
    • Financial toxicity despite JKN/BPJS coverage for cancer care.
    3) Regional Highlights
    • HPV vaccination scaled nationally for Grade 5–6 girls and out-of-school 11–12y via school programmes.

Need someone to talk to, anytime?

Our AI Chat is trained to support you with:

  • Gentle answers to medical questions (in clear, human language)
  • Answer health questions in simple, caring language
  • Help you find the right info on our website
  • Suggest clinics, support groups, and next steps
  • Be a listening ear when you need one
Support 24\7

Start using our chat right now

AI Chat